The molecular basis of Streptococcus equi infection and disease

Microbes and Infection

Volumn 4, Issue 4, 2002, Pages 501-510

  Harrington, Dean J ^a   Sutcliffe, Iain C ^b   Chanter, Neil ^c  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

^c ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Group C streptococcus; Strangles; Streptococcus equi; Virulence factors

Indexed keywords

BACTERIAL PROTEIN; HYALURONATE ASSOCIATED PROTEIN; LIVE VACCINE; STREPTOCOCCUS EQUI M PROTEIN; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL WELFARE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; DRUG EFFICACY; ECONOMIC ASPECT; HORSE DISEASE; INFECTION PREVENTION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS EQUI; VACCINATION;

ANIMALS; BACTERIAL ADHESION; BACTERIAL PROTEINS; CARRIER PROTEINS; HORSE DISEASES; HORSES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS EQUI; VIRULENCE;

ANIMALIA; EQUUS CABALLUS; STREPTOCOCCUS; STREPTOCOCCUS EQUI; STREPTOCOCCUS SP. 'GROUP C';

EID: 0036220868     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01565-4     Document Type: Review

References (74)

1. Strangles
2. Complications associated with Streptococcus equi infection on a horse farm
3. Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcus equi
4. Taxonomic studies on streptococci of serological groups C, G and L and possibly related taxa
5. Characterization of the Lancefield group C streptococcus 16S-23S RNA gene intergenic spacer and its potential for identification and sub-specific typing
6. Laboratory diagnosis of strangles and the isolation of atypical Streptococcus equi
7. Streptococci and enterococci as animal pathogens
8. Identification of carriers of Streptococcus equi in a naturally infected herd
9. Description of an epizootic and persistence of Streptococcus equi infections in horses
10. Persistent infection with Streptococcus equi and the epidemiology of strangles
11. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi
12. Detection of Streptococcus equi in equine nasal swabs and washes by DNA amplification
13. Control of strangles outbreaks by isolation of guttural pouch carriers identified using PCR and culture of Streptococcus equi
14. MSCRAMM-mediated adherence of microorganisms to host tissues
15. Streptococcal adhesion and colonization
16. SFS, a novel fibronectin-binding protein from Streptococcus equi inhibits the binding between fibronectin and collagen
17. Pulsed-field electrophoresis of the genes zag and fnz in isolates of Streptococcus equi
18. Comparison of the fibronectin-binding protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference
19. Fibronectin-binding protein of Streptococcus equi subsp. zooepidemicus
20. Fibrinogen binding structures in β-hemolytic streptococci group A, C, and G
21. Fibrinogen binding inhibits the fixation of the third component of human complement on surface of groups A, B, C, and G streptococci
22. Localization and characterization of the ligand-binding domain of the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi
23. Adherence of Streptococcus equi on tongue, cheek and nasal epithelial cells of ponies
24. The role of hyaluronic acid capsular material of Streptococcus equi subsp. zooepidemicus in mediating adherence to HeLa cells and in resisting phagocytosis
25. Multiple adhesins of streptococci
26. The role of lipoteichoic acids on the adherence of Streptococcus equi to epithelial cells
27. Studies with equine streptococci 2. Experimental immunity to Str. equi
28. Studies with equine streptococci 5. Some relations between virulence of Streptococcus equi and immune response in the host
29. In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression
30. Hyaluronate synthase: Cloning and sequencing of the gene from Streptococcus sp.
31. Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis
32. An ectoprotein kinase of group C streptococci binds hyaluronan and regulates capsule formation
33. Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice
34. Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe
35. Characterization of the antiphagocytic activity of equine fibrinogen for Streptococcus equi subsp. equi
36. Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. Equi
37. The protective M proteins of the equine group C streptococci
38. Cloning and sequence- analysis of a protective M-like protein gene from Streptococcus equi subsp. zooepidemicus
39. Inhibitory effects of fibrinogen on phagocytic killing of streptococcal isolates from humans, cattle and horses
40. Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: A mechanism for survival in equine blood
41. Neither the A- nor B-repeat regions of the fibrinogen-binding protein of Streptococcus equi subsp. equi are essential for fibrinogen binding
42. Streptococcus equi with truncated M-proteins isolated from outwardly healthy horses
43. Streptococcus equi but not Streptococcus zooepidemicus produces potent mitogenic responses from equine peripheral blood mononuclear cells
44. Complete genome sequence of an M1 strain of Streptococcus pyogenes
45. Identification and characterization of novel superantigens from Streptococcus pyogenes
46. Identification of streptococci to species-level by sequencing the gene encoding the manganese-dependent superoxide dismutase
47. Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae
48. Demonstration of a new type of immunoglobulin G receptor in Streptococcus zooepidemicus strains
49. Characterization of acid phosphatase activities in the equine pathogen Streptococcus equi
50. Cytoplasmic membrane lipoprotein LppC of Streptococcus equisimilis functions as an acid phosphatase
51. Lipoproteins of Gram-positive bacteria
52. Identification of homologues of the pneumococcal PsaA protein in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus
53. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae
54. FimA, a major virulence factor associated with Streptococcus sanguis endocarditis
55. Genetic characterization of a Streptococcus mutans LraI family operon and role in virulence
56. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin
57. Is the Ami-AliA/B oligopeptide permease of Streptococcus pneumoniae involved in sensing environmental conditions?
58. Isolation and characterization of hyaluronidases from Streptococcus dysgalactiae, S. zooepidemicus and S. equi
59. Characterization of the haemolytic activity of Streptococcus equi
60. Insertional inactivation of streptolysin S expression is associated with altered riboflavin metabolism in Streptococcus pyogenes
61. Strangles: Streptococcus equi infection in horses
62. Serum bactericidal responses to Streptococcus equi of horses following infection or vaccination
63. Strangles in horse studs: Incidence, risk factors and effects of vaccination
64. Field evaluation of a commercial M-protein vaccine against Streptococcus equi infection in foals
65. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system
66. Equine vaccination
67. Investigations towards an efficacious and safe strangles vaccine: Submucosal vaccination with a live attenuated Streptococcus equi